Search
for
Sort by
Research 30 of 1000+
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- JAK Inhibitors for Treatment of Alopecia Areata
- JAK inhibitors and alopecia areata
- JAK-inhibitors in dermatology: current evidence and future applications
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- Emerging drugs for alopecia areata: JAK inhibitors
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells
- Under Development JAK Inhibitors for Dermatologic Diseases
- JAK Inhibitors in the Treatment of Lichen Planopilaris
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- JAK Inhibitors: A New Weapon in the Skin Care Providers' Arsenal.